Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongshuan Jiuxin tablets for stable angina (phase II)
CTR20131333Phase 2Completed
- Sponsor
- Xi'an Jinhua Enterprise Group
- Start
- Nov 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Tongshuan Jiuxin Pian in coronary arteriosclerosis, angina pectoris, sponsored by Xi'an Jinhua Enterprise Group. Started Nov 2014; status: completed.
02
Drugs
Tongshuan Jiuxin Pian
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on CTR20131333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131333.